Golkor Inc. 8-K
Research Summary
AI-generated summary
Golkor Inc. Announces Prepay Offtake Agreements; Appoints CFO
What Happened
- Golkor Inc. (GKOR) filed an 8-K disclosing a set of commercial agreements tied to the EBM Tailing and Industrial Processing Facility and the appointment of a new Chief Financial Officer. On March 10, 2026 Golkor entered a Prepay Offtake Agreement with Afrikor Metal Industries (Pty) Ltd. (AMI), amended by an addendum on April 3, 2026. Separately, on February 24, 2026 Golkor and Trafigura Pte Ltd. agreed a Purchase Contract for refined silver produced from the EBM Facility. On March 27, 2026 Golkor appointed Robert Armstrong as CFO.
Key Details
- Estimated EBM resource: >8,000,000 ounces of silver, ~170,000 tons zinc and ~50,000 tons lead.
- Offtake terms with AMI: AMI will sell Golkor 100% of silver bullion from Total Production for three years, subject to a minimum delivery of 2,500,000 ounces of silver bullion.
- Prepayment facility: AMI may request up to US$20,000,000 in prepayments against future amounts due under the Prepay Offtake Agreement.
- Trafigura purchase contract: Trafigura will buy not less than 2,500,000 ounces of silver bullion/dore (pricing tied to the London Silver Fixing in USD); deliveries are contingent on AMI completing its purchase of the EBM Facility and subsequent production.
- CFO appointment: Robert Armstrong named CFO effective March 27, 2026; over 20 years of CFO experience, former auditor at Deloitte, B.S. in Business Administration (Ohio State). No related-party or reportable transactions disclosed.
Why It Matters
- These agreements link Golkor’s near-term silver sales and cash flow to the EBM Facility’s production and AMI’s completion of its purchase. The prepay feature could provide up-front funding (up to $20M) but also creates obligations tied to future metal deliveries. The Trafigura contract secures a buyer and market-based pricing for at least 2.5M ounces, contingent on the facility becoming operational. The CFO hire updates management continuity and financial oversight as the company moves toward monetizing the EBM assets.
Loading document...